Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2026-01-22 @ 4:45 PM
Study NCT ID:
NCT07016412
Status:
RECRUITING
Last Update Posted:
2025-10-14
First Post:
2025-06-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD
Sponsor:
Verona Pharma plc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-31
Start Date Type:
ACTUAL
Primary Completion Date:
2026-04-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-04-29
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-03
First Submit QC Date:
None
Study First Post Date:
2025-06-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-10
Last Update Post Date:
2025-10-14
Last Update Post Date Type:
ESTIMATED